Hyppigheden af alvorlige blødninger (inklusive blødninger fra sår) er mindre end 2%.
The most commonly reported adverse reactions are bleedings occurring in total in approximately 14% of patients; the frequency of major bleeds (including wound site bleedings) is less than 2%.